⌘K

Login Start Free

Home/Filings/4/0001562180-25-000235

4//SEC Filing

Hassan Fred 4

Accession 0001562180-25-000235

CIK 0001314102other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:05 PM ET

Size

5.7 KB

Accession

0001562180-25-000235

Insider Transaction Report

Form 4

Period: 2025-01-03

EyePoint Pharmaceuticals, Inc.EYPT

Director

Transactions

Award
Stock Option (Right to Buy)
2025-01-03+40,000→ 40,000 total
Exercise: $8.26From: 2026-01-03Exp: 2035-01-03→ Common Stock (40,000 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1

filerCIK 0001110744

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:05 PM ET
Size: 5.7 KB

View on SEC.gov